1. Home
  2. LXRX vs FET Comparison

LXRX vs FET Comparison

Compare LXRX & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FET
  • Stock Information
  • Founded
  • LXRX 1995
  • FET 2005
  • Country
  • LXRX United States
  • FET United States
  • Employees
  • LXRX N/A
  • FET N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FET Metal Fabrications
  • Sector
  • LXRX Health Care
  • FET Industrials
  • Exchange
  • LXRX Nasdaq
  • FET Nasdaq
  • Market Cap
  • LXRX 228.8M
  • FET 187.2M
  • IPO Year
  • LXRX 2000
  • FET 2012
  • Fundamental
  • Price
  • LXRX $0.75
  • FET $19.76
  • Analyst Decision
  • LXRX Buy
  • FET
  • Analyst Count
  • LXRX 4
  • FET 0
  • Target Price
  • LXRX $3.67
  • FET N/A
  • AVG Volume (30 Days)
  • LXRX 3.7M
  • FET 61.2K
  • Earning Date
  • LXRX 07-31-2025
  • FET 07-31-2025
  • Dividend Yield
  • LXRX N/A
  • FET N/A
  • EPS Growth
  • LXRX N/A
  • FET N/A
  • EPS
  • LXRX N/A
  • FET N/A
  • Revenue
  • LXRX $31,213,000.00
  • FET $807,312,000.00
  • Revenue This Year
  • LXRX N/A
  • FET N/A
  • Revenue Next Year
  • LXRX N/A
  • FET $1.73
  • P/E Ratio
  • LXRX N/A
  • FET N/A
  • Revenue Growth
  • LXRX 1251.21
  • FET 7.31
  • 52 Week Low
  • LXRX $0.28
  • FET $12.78
  • 52 Week High
  • LXRX $2.45
  • FET $21.57
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 61.01
  • FET 74.24
  • Support Level
  • LXRX $0.64
  • FET $19.50
  • Resistance Level
  • LXRX $0.77
  • FET $20.66
  • Average True Range (ATR)
  • LXRX 0.06
  • FET 0.84
  • MACD
  • LXRX 0.00
  • FET 0.43
  • Stochastic Oscillator
  • LXRX 76.47
  • FET 88.42

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

Share on Social Networks: